Quality of life in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysis

被引：0
|
作者：
Wei Liu
Qian Zhang
Tiantian Zhang
Li Li
Chunhua Xu
机构：
[1] Affiliated Nanjing Brain Hospital,Department of Respiratory Medicine
[2] Nanjing Medical University,undefined
[3] Clinical Center of Nanjing Respiratory Diseases and Imaging,undefined
来源：
World Journal of Surgical Oncology | / 20卷
关键词：
PD-1/PD-L1 inhibitors; Chemotherapy; Quality of life; Non-small cell lung cancer; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] The predictive value of PD-L1 expression in patients with advanced hepatocellular carcinoma treated with PD-1/PD-L1 inhibitors: A systematic review and meta-analysis
    Yang, Yao
    Chen, Dongbo
    Zhao, Bigeng
    Ren, Liying
    Huang, Rui
    Feng, Bo
    Chen, Hongsong
    [J]. CANCER MEDICINE, 2023, 12 (08): : 9282 - 9292
  • [42] Effect of PD-L1 Expression for the PD-1/L1 Inhibitors on Non-small Cell Lung Cancer: A Meta-analysis Based on Randomised Controlled Trials
    Xu, Z.
    Lang, J.
    Fu, R.
    Yang, L.
    Chen, Y. Xin
    Ren, W.
    Lu, Y.
    Qiu, X.
    Gu, Q.
    [J]. CLINICAL ONCOLOGY, 2023, 35 (10) : 640 - 651
  • [43] PD-1/PD-L1 Inhibitors plus Chemotherapy Versus Chemotherapy Alone for Resectable Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Pasqualotto, Eric
    de Moraes, Francisco Cezar Aquino
    Chavez, Matheus Pedrotti
    Souza, Maria Eduarda Cavalcanti
    Rodrigues, Anna Luiza Soares de Oliveira
    Ferreira, Rafael Oliva Morgado
    Lopes, Lucca Moreira
    de Almeida, Artur Menegaz
    Fernandes, Marianne Rodrigues
    dos Santos, Ney Pereira Carneiro
    [J]. CANCERS, 2023, 15 (21)
  • [44] Evaluation of rare but severe immune related adverse effects in PD-1 and PD-L1 inhibitors in non-small cell lung cancer: a meta-analysis
    Hu, Yang-Bo
    Zhang, Qun
    Li, Hui-Juan
    Michot, Jean Maire
    Liu, Hong-Bing
    Zhan, Ping
    Lv, Tang-Feng
    Song, Yong
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 : S8 - S20
  • [45] Correlation between immune-related adverse events and the efficacy of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: systematic review and meta-analysis
    Qian Zhang
    Wei Wang
    Qi Yuan
    Li Li
    Yu-Chao Wang
    Chuan-Zhen Chi
    Chun-Hua Xu
    [J]. Cancer Chemotherapy and Pharmacology, 2022, 89 : 1 - 9
  • [46] Correlation between immune-related adverse events and the efficacy of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: systematic review and meta-analysis
    Zhang, Qian
    Wang, Wei
    Yuan, Qi
    Li, Li
    Wang, Yu-Chao
    Chi, Chuan-Zhen
    Xu, Chun-Hua
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (01) : 1 - 9
  • [47] Neutrophil-to-Lymphocyte Ratio Complements the Prognostic Ability of PD-L1 in Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors
    Saravia, D.
    Agte, S.
    Okabe, N.
    Park, W.
    Kwon, D.
    Mudad, R.
    Suzuki, H.
    Chae, Y.
    Oh, M.
    Rahbari, A.
    Lopes, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S696 - S696
  • [48] Prognostic role of neutrophil/lymphocyte ratio (NLR) in patients with non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors: a meta-analysis
    Zhang, Yu
    Wang, Wei
    LYu, Lan
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (12): : 9194 - 9206
  • [49] The efficacy and safety of PD-1/PD-L1 inhibitors versus chemotherapy in patients with previously treated advanced non-small-cell lung cancer A meta-analysis
    Wu, Lin-guang-jin
    Zhou, Dan-ni
    Wang, Ting
    Ma, Jun-zhi
    Sui, Hua
    Deng, Wan-li
    [J]. MEDICINE, 2021, 100 (12) : E25145
  • [50] Clinical benefits of PD-1/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis
    Xiao Zhang
    Zhengyang Yang
    Yongbo An
    Yishan Liu
    Qi Wei
    Fengming Xu
    Hongwei Yao
    Zhongtao Zhang
    [J]. World Journal of Surgical Oncology, 20
12345